Gene · 3007
H1-3: H1.3 linker histone, cluster member
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. H1-3: H1.3 linker histone, cluster member. Genes, record 3007. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3007
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P16402 | Histone H1.3 | 221 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents35
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 49165 | P16402 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1129 | P16402 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 800 | P16402 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4417 | P16402 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 800 | P16402 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1129 | P16402 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4417 | P16402 | Espacenet |
| JP 2024016122 A | 2024-02-06 | 110 | P16402 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 38463 | P16402 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 141434 | P16402 | Espacenet |
1 to 10 of 35
See all 35 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants813
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | H1-3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016058 | Cancer Center Support Grant | 7 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 4 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| R01AI145870 | Development of vaccination strategies to elicit broadly protective immunity against influenza | 4 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA091842 | Cancer Center Support Grant | 3 | 2025 |
| ZIAAI000986 | Influenza Viral Pathogenesis | 3 | 2025 |
| ZIAES071006 | Epigenetic and Transcriptional Functions of Nuclear Receptors and Chromatin Remodeling Proteins in Stem and Cancer Cells | 3 | 2025 |
| ZIASC000550 | Lymphoma Disease Discovery and Definition | 3 | 2025 |
1 to 10 of 813Source NIH's project files
See all 813 nih grantsPapers2,313
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inferring genetic associations of programmed cell death genes with retinitis pigmentosa through multimodal Mendelian randomization. | Mol Med | 2026 | 42365225 | PubTator, text mining | PubMed |
| Transcriptional interference drives intronic polyadenylation at the endogenous H13/Mcts2 locus. | Nucleic Acids Res | 2026 | 42363762 | PubTator, text mining | PubMed |
| H1.3 depletion in AML cells prompts H1.2 redistribution, chromatin remodeling and cell cycle defects. | Epigenetics Chromatin | 2026 | 42098859 | PubTator, text mining | PubMed |
| Applying the Stimulus - Organism - Response framework for exploring use intention - a case study for a digital cultural and creative product, The Forbidden City 365 app. | PLoS One | 2026 | 41801927 | PubTator, text mining | PubMed |
| From virtual attachments to real-world fertility desires: emotional pathways in game character attachment and parasocial relationships. | Front Psychol | 2026 | 41768152 | PubTator, text mining | PubMed |
| Functional Analyses of the Histone-like A104R Protein of African Swine Fever Virus and of a Homologous Pseudogene Product Found in Soft Tick Genomes. | Viruses | 2026 | 41754615 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Profile Associated with Sub-Subtype A6 and CRF63-02A6 HIV-1 Strain Infection. | Viruses | 2026 | 41754547 | PubTator, text mining | PubMed |
| Integrative computational, synthetic, experimental evaluation of targeted inhibitors against matrix metalloproteinase-9: Toward precision modulation of proteolytic activity. | PLoS One | 2026 | 41701802 | PubTator, text mining | PubMed |
| Exploring key predictors of ChatGPT adoption in higher education: insights from UTAUT3 and ARCS model. | BMC Psychol | 2026 | 41664152 | PubTator, text mining | PubMed |
| Resident CD49a+CD103+NKG2C+ NK cells restrict HIV infection in human lymphoid tissue explants. | Sci Adv | 2026 | 41576166 | PubTator, text mining | PubMed |
1 to 10 of 2,313
See all 2,313 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3007
GET https://conductscience.org/api/genes/v1/3007/patents?page=2